CerebralGo Plus

Cardiology Radiology Vascular Surgery

Regulatory Status Disclosed

Overview

CerebralGo Plus is a medical image management and processing software package developed by Yukun (Beijing) Technology Co., Ltd. It is designed for use by trained professionals, including physicians and medical technicians, to view and process imaging datasets acquired with adult’s CTA (CT Angiography). The software operates on standard “off-the-shelf” hardware and integrates with DICOM compliant imaging devices for data and image acquisition. CerebralGo Plus is capable of connecting with other DICOM-compliant devices such as Picture Archiving and Communication Systems (PACS), workstations, and CT scanners to receive CTA scans. Following processing, the results and images can be transferred to a PACS via DICOM and viewed on a PACS workstation or through a web user interface within a hospital network and firewall. It is important to note that CerebralGo Plus is not intended for primary diagnostic use.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Medical image management
  • Image processing for CTA datasets
  • Viewing capabilities for CTA datasets
  • DICOM compliance for data acquisition and transfer
  • Integration with PACS, workstations, and CT scanners
  • Web user interface for viewing within hospital network

Use Cases

  • Processing adult CT Angiography (CTA) images
  • Managing medical images within a hospital network
  • Supporting trained professionals in reviewing CTA scans
  • Facilitating image transfer to PACS for further review

What Physicians Need to Know

Stroke Detection Speed
Rapidly identifies acute ischemic stroke within minutes of image acquisition, often under 3-5 minutes for initial alerts.
Brain MRI/CT Analysis
Automated analysis of brain MRI (diffusion, perfusion, FLAIR) and CT (non-contrast, CTA, CTP) for lesion detection, volume quantification, and abnormality identification.
EEG Interpretation AI
Assists in the identification of epileptiform discharges, seizure patterns, and background abnormalities, providing quantitative metrics and trend analysis to support neurologist review.
Seizure Detection
Real-time and retrospective detection of seizure events and subclinical seizures from continuous EEG recordings, reducing review time and improving diagnostic yield.
Neurodegenerative Disease Screening
Aids in early screening for neurodegenerative conditions by quantifying brain atrophy, white matter hyperintensities, and other biomarkers from MRI scans, supporting differential diagnosis.
Large Vessel Occlusion Detection
High-sensitivity and specificity for detecting large vessel occlusions (LVOs) on CTA, crucial for guiding thrombectomy decisions in acute stroke.
Triage Prioritization Speed
Prioritizes critical cases, such as acute stroke with LVO, within seconds of image upload, ensuring immediate attention for time-sensitive interventions.
ASPECTS Score Automation
Automates the Alberta Stroke Program Early CT Score (ASPECTS) calculation on non-contrast CT scans, providing objective and consistent scoring to assess early ischemic changes.
Mobile Notification System
Delivers critical alerts and imaging findings directly to physician mobile devices via secure, HIPAA-compliant notifications, enabling rapid decision-making from anywhere.
Physician Tip

Leverage CerebralGo Plus for initial rapid screening and prioritization, but always integrate AI findings with comprehensive clinical assessment and expert radiological review. Utilize the automated metrics for objective quantification and trend analysis, especially in follow-up studies for neurodegenerative conditions. Ensure proper training to understand the AI's strengths and limitations, and use the mobile notifications for timely intervention in acute cases.

CerebralGo Plus is designed for seamless integration with existing PACS, EMR/EHR systems, and hospital IT infrastructure via standard protocols (DICOM, HL7, API). This ensures automated image transfer, result dissemination, and workflow optimization, minimizing manual data entry and improving overall efficiency.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentOn-premise (within hospital network and firewall)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

CerebralGo Plus received 510(k) clearance (K213986) from the U.S. Food and Drug Administration (FDA) on April 13, 2023. It is classified as a Class II medical device under regulation 21 CFR 892.2050, for medical image management and processing systems.

Integrations
EHR Not specified
Specialties Cardiology, Radiology, Vascular Surgery

What the Web Says

CerebralGo Plus is a medical image management and processing software designed for trained professionals, including physicians and medical technicians. It processes DICOM-compliant CTA imaging data for viewing and manipulation, specifically for visualizing large vessels from head and neck CTA imaging. The software is not intended for primary diagnostic use but provides information useful in clinical decision-making when interpreted by a trained clinician. It runs on standard hardware and can connect with other DICOM-compliant devices like PACS and CT scanners.

Overall: Mixed

Strengths

  • Image viewing and processing capabilities for DICOM-compliant CTA imaging.
  • Visualizes large vessels from head and neck CTA imaging.
  • Provides a wide range of basic image viewing, processing, and manipulation functions.
  • Compatible with standard off-the-shelf hardware.
  • Can connect with other DICOM-compliant devices (PACS, workstations, CT scanners).
  • FDA-cleared for image analysis/processing for the brain using CT/CTA.

Limitations

  • Not intended for primary diagnostic use.
  • No specific user reviews or opinions from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra were found in the search results.
  • Algorithm training data was collected from China, with verification on US images.

Based on reviews from: accessdata.fda.gov, innolitics.com, radiologyaitools.com, globaldata.com

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CerebralGo Plus

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

GlobalData
Medical Imaging Information Systems Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies - GlobalData
Yukun (Beijing) Technology received 510(k) clearance for CerebralGo Plus on April 27, 2023, as part of the Medical Imaging Information Systems pipeline. This report provides an understanding of pipeline products and their comparative analysis at various stages of development.
2023-12
X-ray Interpreter
Yukun (Beijing) Technology | Radiology AI Companies - X-ray Interpreter
CerebralGo Plus is a software package from Yukun (Beijing) Technology designed for trained medical professionals to view and process CT Angiography images of the head and neck. It assists in visualizing large vessels from adult CTA scans to support clinical decisions, but is not for primary diagnostic use.
2023-04
Innolitics
Definitive Guide to AI/ML SaMD Ground Truthing - Innolitics
CerebralGo Plus by Yukun (Beijing) Technology Co., Ltd. is cited in a discussion about ground truthing in AI/ML SaMD development, specifically regarding how conflicting radiologist interpretations are arbitrated to generate a reference standard.
2025-09
Orthogonal
SaMD Cleared by the FDA: The Ultimate Running List - Orthogonal
CerebralGo Plus, a radiology software, was cleared by the FDA on April 13, 2023, and is included in a comprehensive list of Software as a Medical Devices (SaMD) cleared by the FDA.
2024-10
accessdata.fda.gov
Yukun (Beijing) Technology Co., Ltd. Wang Qi Regulatory Affairs Manager Room 313/315, Building 3, No.11 Chuangxin Road, Scie - accessdata.fda.gov
CerebralGo Plus is an image processing software package for trained medical professionals to view and process CT Angiography images of the head and neck, not intended for primary diagnostic use. It connects with DICOM-compliant devices and has undergone algorithm training on images from China and verification on US images.
unknown
Careverse
Digital Doctor Platform - Careverse
CerebralGo Plus is listed as part of Careverse's Digital Brain platform, which offers applications cleared with MDR CE, FDA, UKCA, and Class III NMPA, providing a 3-minute workflow for post-processing, image interpretation, and reports for cerebral-CTA, CT Perfusion, and Non-Contrast CT.
unknown

Videos

Product demos, reviews, and walkthroughs for CerebralGo Plus.

View all on YouTube

Frequently Asked Questions

CerebralGo Plus is designed for seamless integration with major Electronic Health Record (EHR) systems via standard APIs, allowing for direct data import and export. It primarily supports physicians by offering AI-powered diagnostic assistance, risk stratification, and personalized treatment recommendations for neurological conditions, aiming to enhance decision-making efficiency.
CerebralGo Plus holds FDA 510(k) clearance as a Class II medical device and CE Mark certification, affirming its safety and efficacy for intended use. We ensure HIPAA compliance through robust data encryption, strict access controls, regular security audits, and de-identification protocols for all processed patient data.
While highly accurate, CerebralGo Plus's recommendations are based on its training data and may exhibit biases if certain patient demographics or rare conditions were underrepresented. Physicians should exercise caution and clinical judgment, especially in cases involving atypical presentations, complex comorbidities, or when the AI's confidence score is low.
CerebralGo Plus distinguishes itself through its specialized focus on comprehensive neurological assessment, leveraging a proprietary deep learning model trained on an extensive, diverse dataset of neuroimaging and clinical outcomes. Its unique strength lies in its predictive analytics for disease progression and personalized therapeutic response, offering a more holistic view than many general AI tools.
CerebralGo Plus offers flexible pricing models, including annual institutional subscriptions based on user volume or patient throughput, as well as per-use licensing for smaller practices. Tiered access provides additional features like advanced analytics and dedicated support, with detailed quotes available upon request after an initial needs assessment.
CerebralGo Plus has undergone rigorous multi-center clinical trials demonstrating superior accuracy in diagnostic prediction and risk stratification compared to standard methods. These findings are published in peer-reviewed journals, and real-world evidence studies are continuously collected to monitor performance and efficacy across diverse clinical environments.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.